Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Cystic Fibrosis Molecular & Cell Biology and Physiology Basic Science
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • International Physiotherapy Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Risk of Human papilloma virus infection and of cervical lesions in females with cystic fibrosis

  • Read more about Risk of Human papilloma virus infection and of cervical lesions in females with cystic fibrosis

Bone health after lung transplantation in patients with cystic fibrosis

  • Read more about Bone health after lung transplantation in patients with cystic fibrosis

The Presence of Clostridioides difficile in Stool Samples of Children with Cystic Fibrosis

  • Read more about The Presence of Clostridioides difficile in Stool Samples of Children with Cystic Fibrosis

Fundamental and translational research in Cystic Fibrosis – why we still need it

  • Read more about Fundamental and translational research in Cystic Fibrosis – why we still need it

Experiences of people with cystic fibrosis living without Trikafta/Kaftrio

  • Read more about Experiences of people with cystic fibrosis living without Trikafta/Kaftrio

What happens with CFTR inside human cells affected by cystic fibrosis and how the latest CF drugs change the effects

  • Read more about What happens with CFTR inside human cells affected by cystic fibrosis and how the latest CF drugs change the effects

Clinician Perspectives on Assessing for Disordered Eating and Body Image Disturbance in Adolescents and Young Adults with Cystic Fibrosis

  • Read more about Clinician Perspectives on Assessing for Disordered Eating and Body Image Disturbance in Adolescents and Young Adults with Cystic Fibrosis

Mutations carrying premature termination mutations are improved by ELX-02

  • Read more about Mutations carrying premature termination mutations are improved by ELX-02

Increased blood glucose during the night is associated with a lower pulmonary function in adults but not in children with cystic fibrosis.

  • Read more about Increased blood glucose during the night is associated with a lower pulmonary function in adults but not in children with cystic fibrosis.

The effects of Trikafta/Kaftrio on people with CF who have mutations other than the most common CF mutation (F508del)

  • Read more about The effects of Trikafta/Kaftrio on people with CF who have mutations other than the most common CF mutation (F508del)
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2022. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)